← Open Payments lookup

JULIE MABRY: Open Payments

NPI 1326650110 · GREENVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$433 in 21 payments from 13 companies in 2025. Trend: 2023 $1,006 · 2024 $1,031 · 2025 $433

Food & beverage: $433
CompanyPaymentsAmount
Ardelyx, Inc.3$78
Boehringer Ingelheim Pharmaceuticals, Inc.3$56
Amgen Inc.3$56
Novo Nordisk Inc2$52
AstraZeneca Pharmaceuticals LP2$29
Fresenius USA Marketing, Inc.1$24
Aurinia Pharma U.S., Inc.1$23
Bayer Healthcare Pharmaceuticals Inc.1$21
Calliditas Therapeutics US Inc.1$21
Travere Therapeutics, Inc.1$20

Products named: IBSRELA, JARDIANCE, TAVNEOS, Ozempic, Wegovy, VELPHORO, LUPKYNIS, Kerendia.

Industry payments across MS — which companies pay providers there.